ExodusPoint Capital Management LP grew its position in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 1.2% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,164 shares of the biotechnology company’s stock after purchasing an additional 348 shares during the period. […]
Arcturus Therapeutics (ARCT) and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report)’s share price was up 3.8% during trading on Tuesday . The company traded as high as $33.13 and last traded at $32.96. Approximately 41,722 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 445,807 shares. The stock had previously […]
Profund Advisors LLC Acquires New Holdings in Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Arcturus Therapeutics Holdings Inc. , a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and.